Franklin Resources’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$370K Buy
7,600
+165
+2% +$8.03K ﹤0.01% 2454
2025
Q1
$253K Buy
7,435
+429
+6% +$14.6K ﹤0.01% 2550
2024
Q4
$276K Sell
7,006
-91
-1% -$3.58K ﹤0.01% 2531
2024
Q3
$339K Buy
7,097
+800
+13% +$38.3K ﹤0.01% 2437
2024
Q2
$340K Buy
6,297
+23
+0.4% +$1.24K ﹤0.01% 2386
2024
Q1
$428K Buy
6,274
+319
+5% +$21.7K ﹤0.01% 2311
2023
Q4
$373K Sell
5,955
-227,444
-97% -$14.2M ﹤0.01% 2069
2023
Q3
$10.6M Buy
233,399
+201
+0.1% +$9.12K 0.01% 902
2023
Q2
$13.1M Buy
233,198
+35
+0% +$1.97K 0.01% 867
2023
Q1
$10.5M Sell
233,163
-60,908
-21% -$2.75M 0.01% 919
2022
Q4
$12M Sell
294,071
-1,901
-0.6% -$77.3K 0.01% 900
2022
Q3
$19.3M Buy
295,972
+3,326
+1% +$217K 0.01% 772
2022
Q2
$17.8M Sell
292,646
-313
-0.1% -$19K 0.01% 816
2022
Q1
$18.4M Sell
292,959
-19,544
-6% -$1.23M 0.01% 875
2021
Q4
$23.7M Sell
312,503
-6,712
-2% -$509K 0.01% 844
2021
Q3
$35.7M Buy
319,215
+2,525
+0.8% +$283K 0.01% 747
2021
Q2
$51.3M Sell
316,690
-512,664
-62% -$83M 0.02% 646
2021
Q1
$101M Buy
829,354
+4,292
+0.5% +$523K 0.04% 435
2020
Q4
$126M Sell
825,062
-76,751
-9% -$11.8M 0.05% 361
2020
Q3
$75.4M Buy
901,813
+2,292
+0.3% +$192K 0.04% 459
2020
Q2
$83.6M Buy
899,521
+456,574
+103% +$42.4M 0.04% 421
2020
Q1
$18.8M Buy
442,947
+7,303
+2% +$310K 0.01% 682
2019
Q4
$26.5M Buy
435,644
+11,031
+3% +$672K 0.01% 701
2019
Q3
$17.4M Hold
424,613
0.01% 774
2019
Q2
$20M Hold
424,613
0.01% 748
2019
Q1
$15.2M Sell
424,613
-54,750
-11% -$1.96M 0.01% 794
2018
Q4
$13.7M Hold
479,363
0.01% 807
2018
Q3
$21.3M Sell
479,363
-242,420
-34% -$10.8M 0.01% 770
2018
Q2
$42.4M Buy
721,783
+10,050
+1% +$591K 0.02% 573
2018
Q1
$32.5M Sell
711,733
-82,800
-10% -$3.78M 0.02% 654
2017
Q4
$18.7M Buy
794,533
+65,200
+9% +$1.53M 0.01% 809
2017
Q3
$13M Hold
729,333
0.01% 889
2017
Q2
$11.7M Hold
729,333
0.01% 913
2017
Q1
$15.7M Hold
729,333
0.01% 854
2016
Q4
$14.4M Buy
+729,333
New +$14.4M 0.01% 869